Cherkasov et al. engineered an antibody-directed magnetic core–shell MOF through covalently binding anti-HER2 antibody to functional polymer on the surface of MOF, which could target and kill HER2/neu-positive cancer cells (Cherkasov et al., 2020). Here, ERBB2 is linked to cancer.